Showing results (41-50 of 132) with videos related to
Sort By:
Pageof 14
Microbial Drug Resistance (Larchmont, N.Y.)|May 22, 2008
Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccineRobertino Mera, Linda A Miller, Thomas R Fritsche, et al.Diagnostic Microbiology and Infectious Disease|August 26, 2006
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Ronald N Jones, Helio S Sader, Thomas R Fritsche, et al.Diagnostic Microbiology and Infectious Disease|November 5, 2003
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002)Helio S Sader, Thomas R Fritsche, Alan H Mutnick, et al.Diagnostic Microbiology and Infectious Disease|February 10, 2006
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.Diagnostic Microbiology and Infectious Disease|March 21, 2006
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)David M Johnson, Matthew G Stilwell, Thomas R Fritsche, et al.Diagnostic Microbiology and Infectious Disease|August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolatesHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.Diagnostic Microbiology and Infectious Disease|February 20, 2004
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesJennifer M Streit, Thomas R Fritsche, Helio S Sader, et al.Diagnostic Microbiology and Infectious Disease|August 18, 2005
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unitHelio S Sader, Ronald N Jones, Michael J Dowzicky, et al.Journal of Clinical Microbiology|October 6, 2006
Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004)Lalitagauri M Deshpande, Helio S Sader, Thomas R Fritsche, et al.Diagnostic Microbiology and Infectious Disease|August 28, 2007
LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)Ronald N Jones, Thomas R Fritsche, Helio S Sader, et al.Pageof 14